SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Virtus Convertible & Income Fund II (NCZ) trades at a trailing P/E of 21.3. Trailing earnings yield is 4.69%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (21.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (4.69%).
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.69% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 76/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NCZ
Valuation Multiples
P/E (TTM)21.3
Forward P/EN/A
PEG Ratio0.01
Forward PEGN/A
P/B Ratio0.00
P/S Ratio5.28
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.69
Book Value / Share$0.00
Revenue / Share$2.78
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.69%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-1.80 |
$10.74M |
$-133.89M |
-1246.3% |
| 2016 |
$1.96 |
$17.19M |
$145.9M |
848.6% |
| 2017 |
$0.55 |
$37.13M |
$36.3M |
97.8% |
| 2018 |
$-0.08 |
$-4.58M |
$-5.71M |
- |
| 2019 |
$0.31 |
$35.48M |
$34.68M |
97.7% |
| 2020 |
$1.46 |
$118.65M |
$117.88M |
99.4% |
| 2021 |
$0.00 |
$22.02M |
$-28.38M |
-128.9% |
| 2022 |
$-0.93 |
$19.49M |
$-61.7M |
-316.6% |
| 2023 |
$0.02 |
$18.27M |
$7.39M |
40.4% |
| 2024 |
$0.69 |
$52.95M |
$52.45M |
99.1% |
